Raidium
AI-powered radiology platform for medical imaging analysis
Platform · Cloud SaaSCompany source
Company profile
About Raidium
Raidium is a company based in France that operates within the Medical Imaging & Radiology sector. The company's website provides minimal publicly accessible information about its specific offerings, technology approach, or target market segments. Without detailed content from the homepage or additional pages, it is not possible to provide a comprehensive overview of Raidium's products, services, clinical focus areas, or the healthcare providers and institutions it serves. The company may be in early stages of development, operating in stealth mode, or maintaining a private profile with information shared primarily through direct business relationships rather than public web presence. Further investigation through alternative sources such as LinkedIn, industry databases, or direct company contact would be necessary to build a complete profile of Raidium's operations, technology platform, and market positioning within the medical imaging and radiology AI landscape.
Company description Raidium official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Raidium?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
No customer types are currently listed.
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsFrance
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
A Promptable 3D-CT Foundation Model-Based Approach for Pulmonary Embolism.Cardiovascular and interventional radiology · Jun 2, 2026
A promptable CT foundation model for solid tumor evaluation.NPJ precision oncology · Apr 25, 2025
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Raidium
Recent articles published on Raidium's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.